Understanding how HELLS protein helps maintain genome stability
Role of HELLS chromatin remodeler in genome maintenance
This study is looking at a protein called HELLS to see how it helps keep our DNA stable and prevents diseases that can happen when our genetic material isn't working properly, which could help us understand more about certain genetic disorders that affect patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10870181 on NIH RePORTER |
What this research studies
This research investigates the role of the HELLS protein in maintaining genome stability and preventing diseases related to genomic instability. It focuses on how HELLS interacts with chromatin to regulate DNA repair pathways, which are crucial for proper cellular function. Using a fungal model organism, Neurospora crassa, the research aims to uncover the mechanisms by which HELLS contributes to DNA repair and genome maintenance, potentially revealing new insights into genetic disorders. Patients may benefit from a better understanding of how disruptions in these processes can lead to diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders related to DNA repair deficiencies or genomic instability.
Not a fit: Patients with conditions unrelated to DNA repair or chromatin remodeling may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating diseases caused by genomic instability.
How similar studies have performed: While the role of chromatin remodelers in DNA repair is an emerging field, previous studies have shown promising results in understanding similar mechanisms, indicating potential for success.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Czaja, Wioletta — University of Alabama at Birmingham
- Study coordinator: Czaja, Wioletta
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.